Guoji Yanke Zazhi (Dec 2018)

Influencing factors of serum Lp-PLA2 level in patients with diabetic retinopathy

  • Zhao-Hui Hui,
  • Yong-Ding Zhang,
  • Qing-Xia Zhang,
  • Yan Sun,
  • Qiong-Mei Shi,
  • Fang Ma

DOI
https://doi.org/10.3980/j.issn.1672-5123.2018.12.21
Journal volume & issue
Vol. 18, no. 12
pp. 2213 – 2216

Abstract

Read online

AIM: To probe into the related influencing factors of serum lipoprotein associated phospholipase A2(Lp-PLA2)level in patients with diabetic retinopathy. METHODS: Totally 174 cases of patients with type 2 diabetes mellitus and who treated in Department of Endocrinology from September 2015 to September 2017 were selected as the research objects, and were divided into the non-diabetic retinopathy group(NDR), non-proliferative diabetic retinopathy group(NPDR)and proliferative diabetic retinopathy group(PDR)according to the results of fundus examination. Then, the age, sex, body mass index(BMI), blood pressure, blood glucose, blood lipids, vascular endothelial growth factor(VEGF), C-reactive protein(CRP), and Lp-PLA2 levels and other clinical data of three groups of patients were collected and compared. RESULTS: There was significant differences in the duration of diabetes, fasting blood glucose(FBP), 2h postprandial blood glucose(2hBP), HbA1c, triacylglycerol(TG), total cholesterol(TC), high density lipoprotein cholesterol(HDL-C), low density lipoprotein cholesterol(LDL-C), VEGF, CRP, Lp-PLA2 between the three groups of patients(PP>0.05). While there was significant difference in biochemical indexes of patients between PDR group and NDR group(PPPPCONCLUSION: The level of serum Lp-PLA2 in patients with diabetic retinopathy are significantly increased, which the level is positively correlated with the duration of diabetes and serum VEGF level, thus it can be used as diagnostic index for diabetic retinopathy.

Keywords